IVS / Biotech Business Seminar

Seminar with Toke Reichstein, IVS.

Innovative Scope in Biotech Business - Effects of aligning partner types with the firm's science base.

The seminar is organized in collaboration with the Research Centre on Biotech Business.

Co-author: Finn Valentin.

Abstract:

Using extensive patent data on Scandinavian Biotech firms together with associated firm level data, this paper explores factors that drive the innovative scope of biotech firms.

Collaborating with pharmaceutical firms, universities and other dedicated biotech firms proves beneficiary in introducing innovations broadening the innovation scope of firms.

Contrasting large and small molecules research firms exhibit noteworthy differences in the type of collaboration partner that allows the firm to expand its innovative scope. This suggests that partner type needs to be aligned with the firm’s science base before collaboration produces innovation in for the firm uncharted technologies.

Additionally, we find that outsourcing and acquisition of innovations increase their scope, lending support to the view that outsourced R&D expands the boundary of the firm’s innovative search.

A paper for the seminar is available upon request (by email).